Is IBIO or IFRX more undervalued in 2026?

CirclFi compares iBio, Inc. (IBIO) and InflaRx N.V. (IFRX) using 13 institutional-grade valuation models. IBIO has a Quality of Company score of 3.6/10 while IFRX scores 1.8/10.

Which is a better buy — IBIO or IFRX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do IBIO and IFRX valuations compare?

IBIO at $1.93 and IFRX at $2.38 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

IBIO vs IFRX Valuation Comparison 2026 — Intrinsic Value Analysis

IBIO

Biotechnology

iBio, Inc.

Quality

3.6

out of 10

Value Trap

SAFE

Price

$1.93

Last close

Models

10/13

Active

IFRX

Biotechnology

InflaRx N.V.

Quality

1.8

out of 10

Value Trap

—

Price

$2.38

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	IBIO Fair Value	IBIO Upside	IFRX Fair Value	IFRX Upside
Bayesian DCF	Intrinsic	$1.04	-46.3%	$0.63	-73.5%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$1.08	-44.0%	$0.30	-88.4%
PWERM	Option-Based	$1.96	+1.3%	$0.89	-65.3%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for IBIO vs IFRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

IBIO vs IFRX — Which Stock Is More Undervalued?

IBIO scores higher with a 3.6/10 quality rating vs IFRX's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing iBio, Inc. (IBIO) and InflaRx N.V. (IFRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

IBIO currently trades at $1.93 with a QOC of 3.6/10, while IFRX trades at $2.38 with a QOC of 1.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).